{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:23:11Z","timestamp":1790230991457,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semcancer.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T17:15:44Z","timestamp":1485105344000},"page":"134-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"special_numbering":"C","title":["Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH"],"prefix":"10.1016","volume":"43","author":[{"given":"Laurent","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid O.","family":"Alfarouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgelindo","family":"Da Veiga Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2017.01.005_bib0005","first-page":"1","article-title":"Tumor metabolism, cancer cell transporters, and microenvironmental resistance","volume":"6366","author":"Alfarouk","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.18632\/oncoscience.109","article-title":"Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question","volume":"1","author":"Alfarouk","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0030","series-title":"Cancer: A Dysmethylation Syndrome","author":"Israel","year":"2005"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/metabo6040033","article-title":"The redox status of cancer cells supports mechanisms behind the Warburg effect","volume":"6","author":"Moreira","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-7-7","article-title":"Cancer as a metabolic disease","volume":"7","author":"Seyfried","year":"2010","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1476-4598-10-70","article-title":"The metabolic advantage of tumor cells","volume":"10","author":"Isra\u00ebl","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12976-015-0005-2","article-title":"Cell cycle progression is regulated by intertwined redox oscillators","volume":"12","author":"da Veiga Moreira","year":"2015","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.semcancer.2005.04.009","article-title":"Pyruvate kinase type M2 and its role in tumor growth and spreading","volume":"15","author":"Mazurek","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/cancers3010408","article-title":"Tumor acidity as evolutionary spite","volume":"3","author":"Alfarouk","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0065","first-page":"2185","article-title":"Na+\/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes","volume":"14","author":"Reshkin","year":"2000","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0070","doi-asserted-by":"crossref","unstructured":"R.A. Cardone, V. Casavola, S.J. Reshkin, The role of disturbed pH dynamics and the Na+\/H+ exchanger in metastasis, Nat. Rev. Cancer. 5 (n.d.) 786\u201395. doi:10.1038\/nrc1713.","DOI":"10.1038\/nrc1713"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0075","doi-asserted-by":"crossref","unstructured":"S. Harguindey, G. Orive, J. Luis Pedraz, A. Paradiso, S.J. Reshkin, The role of pH dynamics and the Na+\/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature, Biochim. Biophys. Acta. 1756 (n.d.) 1\u201324. doi:10.1016\/j.bbcan.2005.06.004.","DOI":"10.1016\/j.bbcan.2005.06.004"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0080","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/0008-5472.CAN-06-0983","article-title":"Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice","volume":"66","author":"Rofstad","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-8-57","article-title":"Proton dynamics in cancer","volume":"8","author":"Huber","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0090","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1074\/jbc.M411313200","article-title":"Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling","volume":"280","author":"Kato","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0095","first-page":"6045","article-title":"Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles","volume":"50","author":"Montcourrier","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0100","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.87.19.7414","article-title":"Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions","volume":"87","author":"Gillies","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.ph.48.030186.002051","article-title":"Effects of growth factors on intracellular pH regulation","volume":"48","author":"Moolenaar","year":"1986","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyss\u00e9gur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0120","series-title":"Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer","author":"Seyfried","year":"2012"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0065-230X(05)94003-7","article-title":"Mitochondria as functional targets of proteins coded by human tumor viruses","volume":"94","author":"D\u2019Agostino","year":"2005","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0130","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"J. Int. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0135","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00154-08","article-title":"Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential","volume":"82","author":"Clippinger","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2009.04.010","article-title":"Hepatitis B virus X gene is implicated in liver carcinogenesis","volume":"286","author":"Koike","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0145","first-page":"307","article-title":"On the formation of lactic acid with growth","volume":"160","author":"Warburg","year":"1925","journal-title":"Biochem. Z."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-012-2283-2","article-title":"Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity","volume":"136","author":"Elliott","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0155","doi-asserted-by":"crossref","first-page":"e61747","DOI":"10.1371\/journal.pone.0061747","article-title":"Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways","volume":"8","author":"Kaipparettu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0160","first-page":"49","article-title":"PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment","volume":"32","author":"Gu\u00e9nin","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0165","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1541-7786.MCR-07-2130","article-title":"SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism","volume":"6","author":"Liang","year":"2008","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12012-007-0008-2","article-title":"Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis","volume":"7","author":"Wallace","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10863-006-9059-5","article-title":"Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer","volume":"39","author":"Cullen","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3892\/or_00000778","article-title":"A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary resuzlts","volume":"23","author":"Schwartz","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10637-012-9849-z","article-title":"Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin","volume":"31","author":"Schwartz","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0190","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00109-011-0785-8","article-title":"Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo","volume":"89","author":"Zachar","year":"2011","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0195","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10637-011-9692-7","article-title":"Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice","volume":"30","author":"Abolhassani","year":"2012","journal-title":"Invest. New Drugs"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.005_bib0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10495-005-0810-x","article-title":"alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation","volume":"10","author":"Wenzel","year":"2005","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0210","first-page":"219","article-title":"Early clinical and toxicological results of a combination of natural glycolysis inhibitors (METABLOC\u2122) on cancer patients","volume":"23","author":"Baronzio","year":"2012","journal-title":"Biomed. Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0215","first-page":"973","article-title":"Metabolic treatment of cancer: intermediate results of a prospective case series","volume":"34","author":"Schwartz","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0220","first-page":"13","article-title":"Metabolic cancer treatment: intermediate results of a clinical study","volume":"10","author":"Schwartz","year":"2014","journal-title":"Cancer Ther."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0225","first-page":"20","article-title":"The addition of chloroquine and metformine to Metabloc induces a rapid drop of tumor markers in advanced carcinoma","volume":"10","author":"Schwartz","year":"2014","journal-title":"Cancer Ther."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0230","article-title":"Combination of metabolic treatment of aggressive primary brain tumour and multiple metastases of the brain","volume":"2","author":"Schwartz","year":"2016","journal-title":"Cancer Res. Oncol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1574892811308010085","article-title":"Na+-H+ exchanger, pH regulation and cancer","volume":"8","author":"Reshkin","year":"2013","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0240","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1158\/0008-5472.CAN-07-1805","article-title":"Targeting vacuolar H+-ATPases as a new strategy against cancer","volume":"67","author":"Fais","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0245","first-page":"1069","article-title":"The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification","volume":"19","author":"Cosentini","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0250","first-page":"621","article-title":"Tumor cell sensitivity to hyperthermia as a function of extracellular and intracellular pH","volume":"65","author":"Hofer","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0255","first-page":"4364","article-title":"Effects of systemic acidification of mice with Sarcoma 180","volume":"39","author":"Harguindey","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0260","first-page":"2715","article-title":"Proton channels and exchangers in cancer","volume":"2014","author":"Spugnini","year":"1848","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0265","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-014-9531-3","article-title":"Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy","volume":"33","author":"Fais","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0270","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0305-7372(03)00106-3","article-title":"Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy","volume":"29","author":"Izumi","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0275","first-page":"69","article-title":"Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach","volume":"23","author":"Taylor","year":"2015","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0280","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"De Milito","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"De Milito","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.005_bib0290","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1479-5876-11-268","article-title":"Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients\u2019 bed","volume":"11","author":"Ferrari","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0295","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-015-0194-x","article-title":"Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer","volume":"34","author":"Wang","year":"2015","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"12","key":"10.1016\/j.semcancer.2017.01.005_bib0300","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.dld.2016.08.126","article-title":"High-doses of proton pumps inhibitors in refractory gastro-intestinal cancer: a case series and the state of art","volume":"48","author":"Falcone","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1479-5876-9-221","article-title":"Lansoprazole as a rescue agent in chemoresistant tumors: a phase I\/II study in companion animals with spontaneously occurring tumors","volume":"9","author":"Spugnini","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-014-0225-y","article-title":"High dose lansoprazole combined with metronomic chemotherapy: a phase I\/II study in companion animals with spontaneously occurring tumors","volume":"12","author":"Spugnini","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0315","first-page":"983","article-title":"Use of PET for monitoring cancer therapy and for predicting outcome","volume":"46","author":"Weber","year":"2005","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.semcancer.2017.01.005_bib0320","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/cdd.2014.37","article-title":"Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells","volume":"21","author":"Colak","year":"2014","journal-title":"Cell Death Differ."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T22:57:55Z","timestamp":1536101875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X17300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":64,"alternative-id":["S1044579X17300056"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.01.005","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}